• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

ADC Therapeutics

A series of dice with a bag on them illustrating cost cuts
Favicon Fierce Biotech

ADC Therapeutics shutters UK R&D site, lays off 30% of staff

The company is closing a U.K. R&D facility and laying off a third of its global workforce, an effort that is expected to be complete by Sept. 30.
Gabrielle Masson Jun 12, 2025 3:00pm
Merck KGaA MilliporeSigma US

MilliporeSigma's production push rolls with $76M ADC investment

Oct 29, 2024 10:33am
NandiniPiramal

Piramal to pump $80M into expansion of Kentucky injectables site

Oct 1, 2024 8:12am
Zynlonta

ADC touts early Zynlonta results in marginal zone lymphoma

May 6, 2024 4:19pm
visual rendering of an antibody drug conjugate

Samsung Biologics, LegoChem link to propel ADC development

Feb 7, 2024 10:16am
Asia

Vyvanse, Keytruda-Lenvima, Adagene-ADC—Fierce Pharma Asia

Sep 1, 2023 8:50am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings